892
Views
0
CrossRef citations to date
0
Altmetric
Pharmacology & Pharmaceutics

Effects of the miR-29c/PTEN axis on the PI3 K/Akt/NF-kB pathway in a rat model of severe pneumonia

, , &
Pages 355-364 | Received 17 Jul 2020, Accepted 22 Apr 2021, Published online: 10 May 2021

Figures & data

Figure 1. Lung tissue sections of rats in two groups. The HE staining figures show the model group and control group.

Figure 1. Lung tissue sections of rats in two groups. The HE staining figures show the model group and control group.

Figure 2. Expression of miR-29c and PTEN in serum and tissue of rats in the model and control groups. A) ELISA method for the comparison of miR-29c in serum; B) RT-qPCR method for comparison of miR-29c in lung tissue; C) ELISA method for the comparison of PTEN in serum; D) RT-qPCR method for comparison of PTEN in lung tissue. * indicates P <0.05, When model group compared with the control group.

Figure 2. Expression of miR-29c and PTEN in serum and tissue of rats in the model and control groups. A) ELISA method for the comparison of miR-29c in serum; B) RT-qPCR method for comparison of miR-29c in lung tissue; C) ELISA method for the comparison of PTEN in serum; D) RT-qPCR method for comparison of PTEN in lung tissue. * indicates P <0.05, When model group compared with the control group.

Figure 3. Correlation analysis between miR-29c and PTEN in rats with pneumonia. A) Correlation analysis of miR-29c and PTEN in serum of pneumonia rats; B) Correlation analysis of miR-29c and PTEN in lung tissue of pneumonia rats.

Figure 3. Correlation analysis between miR-29c and PTEN in rats with pneumonia. A) Correlation analysis of miR-29c and PTEN in serum of pneumonia rats; B) Correlation analysis of miR-29c and PTEN in lung tissue of pneumonia rats.

Figure 4. Comparison of apoptosis rate between model and control groups by flow cytometry. * indicates P < 0.05. Flow cytometry method for the column and flow results for apoptosis between model and control groups.

Figure 4. Comparison of apoptosis rate between model and control groups by flow cytometry. * indicates P < 0.05. Flow cytometry method for the column and flow results for apoptosis between model and control groups.

Figure 5. Comparison of protein expression between model and control groups by Western blot. A: Western blot method for column and protein figures for PI3 K expression (ab140307,1:1000) level. B: Western blot method for column and protein figures for Akt (ab38449,1:1000) expression level. C: Western blot method for column and protein figures for NF-kB (ab32536,1:1000) expression level.

Figure 5. Comparison of protein expression between model and control groups by Western blot. A: Western blot method for column and protein figures for PI3 K expression (ab140307,1:1000) level. B: Western blot method for column and protein figures for Akt (ab38449,1:1000) expression level. C: Western blot method for column and protein figures for NF-kB (ab32536,1:1000) expression level.

Figure 6. Protein expression after miR-29c transfection by Western blot. A: Western blot method for column figures for PI3 K(ab140307,1:1000), Akt(ab38449,1:1000), and NF-kB(ab32536,1:1000) proteins expression levels. B: The representative graph of protein expression figures for PI3 K, Akt, and NF-kB proteins expression. * indicates P < 0.05 when compared with the miR-29c-mimics group; # indicates P < 0.05 when compared with the miR-29c-inhibitor group.

Figure 6. Protein expression after miR-29c transfection by Western blot. A: Western blot method for column figures for PI3 K(ab140307,1:1000), Akt(ab38449,1:1000), and NF-kB(ab32536,1:1000) proteins expression levels. B: The representative graph of protein expression figures for PI3 K, Akt, and NF-kB proteins expression. * indicates P < 0.05 when compared with the miR-29c-mimics group; # indicates P < 0.05 when compared with the miR-29c-inhibitor group.

Figure 7. Protein expression after PTEN transfection by Western blot. A) Western blot method for column figures for PI3 K(ab140307,1:1000), Akt(ab38449,1:1000), and NF-kB(ab32536,1:1000) proteins expression. B: The representative graph of protein expression figures for PI3 K, Akt, and NF-kB proteins expression. * indicates P < 0.05 when compared with the sh-PTEN group; # indicates P <0.05 when compared with the si-PTEN group.

Figure 7. Protein expression after PTEN transfection by Western blot. A) Western blot method for column figures for PI3 K(ab140307,1:1000), Akt(ab38449,1:1000), and NF-kB(ab32536,1:1000) proteins expression. B: The representative graph of protein expression figures for PI3 K, Akt, and NF-kB proteins expression. * indicates P < 0.05 when compared with the sh-PTEN group; # indicates P <0.05 when compared with the si-PTEN group.

Figure 8. Detection of PI3 K, Akt, and NF-kB mRNA by RT-qPCR. A) Column figures for PI3 K mRNA expression levels; B) Column figures for Akt mRNA expression levels; C) Column figures for NF-kB mRNA expression levels. * indicates P < 0.05, When model group compared with the control group.

Figure 8. Detection of PI3 K, Akt, and NF-kB mRNA by RT-qPCR. A) Column figures for PI3 K mRNA expression levels; B) Column figures for Akt mRNA expression levels; C) Column figures for NF-kB mRNA expression levels. * indicates P < 0.05, When model group compared with the control group.

Figure 9. The flow diagram of miR-29c/PTEN affects pneumonia through PI3 K/Akt/NF-kB.

Figure 9. The flow diagram of miR-29c/PTEN affects pneumonia through PI3 K/Akt/NF-kB.

Data availability statement

Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.